TY - T1的调查血氧定量法之间的关系恶化趋势在血管内治疗和神经急性缺血性中风患者(S24.006) JF -神经学乔-神经学做- 10.1212 / WNL。首页0000000000202997六世- 100 - 17补充2 SP - 3069 AU - Madelynne Olexa AU - Yelyzaveta Begunova AU -大卫Bartolome盟腾彭AU -查尔斯Matouk盟-凯文Sheth AU -尼尔斯·彼得森Y1 - 2023/04/25 UR - //www.ez-admanager.com/content/100/17_Supplement_2/3069.abstract首页 N2 -目的:分类近红外光谱(NIRS)趋势成描述性的“指纹”并检查这些指纹和神经之间的关系恶化。背景:脑近红外光谱(NIRS)是一个有用的工具在实时监测脑氧化水平。然而,不同氧化程度的机制在血管内血栓切除术(EVT)影响功能的结果仍有待确定。设计/方法:我们登记病人呈现给耶鲁大学纽黑文医院与大血管闭塞急性缺血性中风和接受了EVT。NIRS实施标准操作程序。定义事件的时间戳(药物管理、血管再通等)与相应的同步检测的值。我们检查NIRS曲线从抵达angio-suite血管再通的时间。神经恶化被定义为增加4分或更多在美国国立卫生研究院的中风尺度(署)。结果:48例患者(平均年龄72±13,意味着署14)进行了分析。五个“指纹”观察影响半球:持续减少,向下rSO2山峰,没有变化,向上rSO2山峰,和持续增加,而被分配的名义值−2−1,0,1和2分别。在调整了年龄和入学署,持续减少和下行rSO2峰分别与神经恶化相关(P = 0.0076)。结论:可识别的技术的“指纹”向下孤立rSO2高峰和持续减少在受影响的半球EVT与神经恶化有关。 Further distillation of identifiable intraprocedural NIRS trends in real time could provide guidance for anesthesia and hemodynamic management during EVT to optimize patient outcomes after stroke.Disclosure: Miss Olexa has nothing to disclose. Miss Begunova has nothing to disclose. Mr. Bartolome has nothing to disclose. Dr. Peng has nothing to disclose. Charles Matouk has nothing to disclose. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. Dr. Petersen has received research support from NIH. ER -